Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (Unaudited)

v3.24.1.1.u2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 19,084 $ 17,396
Short term investments 0 8,970
Accounts receivable 1,842 572
Receivable from public grants 3,071 3,141
Other receivables 2,332 2,326
Assets held for sale, property and equipment 196 2,188
Prepaid expenses and other current assets 2,972 4,087
Total current assets 29,497 38,680
Current liabilities:    
Accounts payable 1,518 3,372
Accrued expenses and other current liabilities 6,015 8,550
Total current liabilities 7,533 11,922
Stockholders’ equity:    
Preferred stock 0 0
Common stock 1 1
Additional paid-in capital 342,165 341,693
Accumulated other comprehensive loss (346) 28
Accumulated deficit (319,856) (314,964)
Total stockholders’ equity 21,964 26,758
Total liabilities and stockholders’ equity $ 29,497 $ 38,680